TLR4 TRANSCRIPTION FACTOR ACTIVITY INHIBITOR AND ULCERATIVE COLITIS-ABATING PERIOD-INTRODUCING AGENT OR -MAINTAINING AGENT

Title:

TLR4 TRANSCRIPTION FACTOR ACTIVITY INHIBITOR AND ULCERATIVE COLITIS-ABATING PERIOD-INTRODUCING AGENT OR -MAINTAINING AGENT

Document Type and Number:

Japanese Patent JP2006232786

Kind Code:

A

Abstract:

To provide a TLR4 transcription factor activity inhibitor which inhibits the TLR4 transcription factor and is effective for introducing or maintaining the ulcerative colitis-abating period.

This TLR4 transcription factor activity inhibitor is characterized by containing butyric acid bacteria, butyric acid-producing bacterium metabolite, butyric acid bacterium metabolite or butyric acid.

Inventors:

MASUDA TAKASHI
KATSUNO TATSURO
ISONO TAKASHI
SUZUKI YASUO

Application Number:

JP2005053679A

Publication Date:

September 07, 2006

Filing Date:

February 28, 2005

Export Citation:

Click for automatic bibliography generation Help

Assignee:

TOA YAKUHIN KOGYO KK

International Classes:

A61K35/74; A61K31/19; A61K35/741; A61K35/742; A61K35/744; A61P1/04; A61P43/00

Attorney, Agent or Firm:

Masayuki Kishida
Hiroji Obana
Mizuno Katsufumi
Hiroshin Takano

Previous Patent: TYPE I ALLERGY INHIBITOR USING FULVIC ACID AND METHOD FOR INHIBITING ONSET OF TYPE I ALLERGY

Next Patent: WATER-CONTAINING COMPOSITION CONTAINING WATER-SOLUBLE SILK PROTEIN